Yükleniyor...

Advertisement

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 460 gün önce

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

Etiketler: AMGN

read more

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 366 gün önce

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 522 gün önce

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 638 gün önce

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1012 gün önce

TSX Settles Lower As Trade Tensions Resurface

TSX Settles Lower As Trade Tensions Resurface

Despite hitting record highs earlier in the week, the Canadian market ended weak for a second straight day as trade tensions weighed on sentiment, prompting investors to tread cautiously on Friday.

RTTNews | 1 gün önce

Crude Oil Prices Slip On Friday

Crude Oil Prices Slip On Friday

Crude suffered a weekly loss of more than 1 percent due to uncertainty over U.S. President Donald Trump's tariffs and their likely impact on global growth and fuel demand.

RTTNews | 1 gün önce

Pound Drops As Trade Tensions Renew

Pound Drops As Trade Tensions Renew

The pound fell against its major counterparts in the New York session on Friday, as trade tensions escalated after the U.S. President accused China of violating trade agreement reached earlier this month.

RTTNews | 1 gün önce

Weighed Down By Tariff Uncertainty, Gold Slides

Weighed Down By Tariff Uncertainty, Gold Slides

The swift changes in successive US court rulings on tariffs and a softer inflation report caused a slide in gold price on Friday.

RTTNews | 1 gün önce

Şartlar | Gizlilik | Site Haritası | Site Map Calendar

© 2025 Myfxbook Ltd. Her hakkı saklıdır.

YÜKSEK RİSK UYARI: Döviz trade’i, tüm yatırımcılar için uygun olmayabilecek yüksek düzeyde risk taşır. Kaldıraç, ek risk ve zarara maruz kalma yaratır. Döviz trade’i yapmaya karar vermeden önce yatırım hedeflerinizi, deneyim seviyenizi ve risk toleransınızı dikkatlice değerlendirin. İlk yatırımınızın bir kısmını veya tamamını kaybedebilirsiniz. Kaybetmeyi göze alamayacağınız parayla yatırım yapmayın. Döviz trade’i ile ilgili riskler konusunda kendinizi eğitin ve herhangi bir sorunuz varsa bağımsız bir finans veya vergi danışmanından tavsiye alın. Her türlü veri ve bilgi 'olduğu gibi' yalnızca bilgilendirme amaçlıdır ve trading amaçları veya tavsiye amaçlı değildir. Geçmiş performans gelecekteki sonuçların göstergesi değildir.